Neurorehabilitation Devices

Neurorehabilitation Devices

Global Neurorehabilitation Devices Market to Reach US$4.5 Billion by 2030

The global market for Neurorehabilitation Devices estimated at US$1.6 Billion in the year 2023, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Neurorobotic Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Brain Computer Interface segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$564.4 Million While China is Forecast to Grow at 21.2% CAGR

The Neurorehabilitation Devices market in the U.S. is estimated at US$564.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$628.2 Million by the year 2030 trailing a CAGR of 21.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.2% and 16.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.8% CAGR.

Global Neurorehabilitation Devices Market - Key Trends & Drivers Summarized

Neurorehabilitation devices are specialized tools designed to aid in the recovery and rehabilitation of individuals with neurological disorders and injuries. These devices are used to improve motor function, cognitive abilities, and overall quality of life for patients suffering from conditions such as stroke, spinal cord injuries, traumatic brain injuries, and neurodegenerative diseases like Parkinson’s and multiple sclerosis. Neurorehabilitation devices include robotic exoskeletons, brain-computer interfaces (BCIs), neurostimulation devices, and virtual reality (VR)-based rehabilitation systems. These technologies provide targeted therapy, facilitate repetitive training, and offer real-time feedback to enhance rehabilitation outcomes.

The development and implementation of neurorehabilitation devices are driven by advancements in neuroscience, robotics, and digital health technologies. Robotic exoskeletons and assistive devices enable patients to perform repetitive movements, promoting neuroplasticity and motor recovery. BCIs facilitate communication between the brain and external devices, helping patients regain control over their movements. Neurostimulation devices, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), modulate neural activity to improve cognitive and motor functions. VR-based systems create immersive environments for cognitive and physical exercises, making rehabilitation engaging and effective.

The growth in the neurorehabilitation devices market is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the rising number of stroke and injury cases are significant drivers. Secondly, advancements in neuroscience and rehabilitation technologies are enhancing the effectiveness and adoption of these devices. Thirdly, the growing awareness of the benefits of early and intensive rehabilitation is boosting demand for neurorehabilitation devices. Additionally, the integration of digital health technologies and remote monitoring is making rehabilitation more accessible and personalized. Furthermore, supportive government policies and funding for research and development in neurorehabilitation are encouraging innovation. Lastly, the expansion of healthcare infrastructure and the increasing availability of specialized rehabilitation centers are further driving market growth.

Select Competitors (Total 105 Featured) -

• Abbott Laboratories
• AlterG, Inc.
• Biometrics Ltd.
• Bioness Inc.
• BIONIK Laboratories Corp.
• Boston Scientific Corporation
• Ectron Ltd
• Ekso Bionics Holdings Inc.
• Eodyne
• Helius Medical Technologies
• Hocoma AG
• Instead Technologies Ltd.
• Kinestica
• Medtronic plc
• Neofect
• Neuro Rehab VR
• Reha Technology AG
• Rehab-Robotics Company Limited.
• ReWalk Robotics Ltd.
• Rex Bionics Ltd
• Saebo, Inc.
• Tyromotion GmbH

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.